Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gem-CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00079261Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of gemcitabine in non-Hodgkin lymphoma (NHL), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00079261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079261.